Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |